Development and validation of a novel IL-10 deficient cell transfer model for colitis
Authors:
- 1 June 2005
- journal article
- Published by Elsevier in International Immunopharmacology
- Vol. 5 (6) , 993-1006
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- IL-10 modulates intestinal damage and epithelial cell apoptosis in T cell-mediated enteropathyAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2004
- Defining the roles of perforin, Fas/FasL, and tumour necrosis factor α in T cell induced mucosal damage in the mouse intestineGut, 2002
- The conversion of redox status of peritoneal macrophages during pathological progression of spontaneous inflammatory bowel disease in Janus family tyrosine kinase 3–/– and IL‐2 receptor γ–/– miceInternational Immunology, 2002
- Immunotherapy of Crohn's DiseaseScandinavian Journal of Immunology, 2000
- The Effect of Dexamethasone Treatment on Murine ColitisScandinavian Journal of Gastroenterology, 2000
- Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses.Journal of Clinical Investigation, 1996
- T cells in inflammatory bowel disease: protective and pathogenic rolesImmunity, 1995
- Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)Gastroenterology, 1995
- Inhibition of Thl responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cellsImmunity, 1994
- Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity.Journal of Experimental Medicine, 1994